Sun-Hwa Lee

Title: Innovations of Sun-Hwa Lee

Introduction

Sun-Hwa Lee is a notable inventor based in Daegu, South Korea. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target protein kinase-related diseases. With a total of three patents to his name, his work is recognized for its potential impact on medical treatments.

Latest Patents

Sun-Hwa Lee's latest patents include a pyrrolo-pyrimidine derivative compound and a pyrrolo-pyridine derivative compound. The first patent describes a novel compound that serves as an effective ingredient for preventing or treating protein kinase-related diseases. This compound exhibits outstanding inhibitory activity against LRRK2 kinase and has been verified to have inhibitory activity against various protein kinases. The second patent focuses on a pyrrolo-pyridine derivative compound, which also shows excellent inhibitory activity against various protein kinases, including DYRK1A. This compound is particularly relevant for the prevention and treatment of Alzheimer's disease and related conditions.

Career Highlights

Throughout his career, Sun-Hwa Lee has worked with esteemed organizations such as the Daegu-Gyeongbuk Medical Innovation Foundation and the Korea Research Institute of Bioscience and Biotechnology. His research has contributed to advancements in the understanding and treatment of diseases linked to protein kinases.

Collaborations

Sun-Hwa Lee has collaborated with notable colleagues, including Hwan Geun Choi and Eunhwa Ko. Their combined expertise has furthered the development of innovative solutions in the pharmaceutical field.

Conclusion

Sun-Hwa Lee's contributions to the field of pharmaceutical chemistry through his innovative patents highlight his role as a significant inventor. His work has the potential to lead to effective treatments for serious medical conditions, showcasing the importance of innovation in healthcare.